206 related articles for article (PubMed ID: 29185263)
1. Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients.
Lee KB; Kim YS; Lee JM
J Gynecol Oncol; 2018 Jan; 29(1):e5. PubMed ID: 29185263
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
3. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
5. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
[TBL] [Abstract][Full Text] [Related]
7. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node stage IB/IIA cervical cancer.
Mossa B; Mossa S; Marziani R
Eur J Gynaecol Oncol; 2010; 31(5):545-50. PubMed ID: 21061797
[TBL] [Abstract][Full Text] [Related]
9. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of complete radical hysterectomy in early-stage cervical cancer patients with intra-operative detection of nodal metastases.
Tuipae S; Wongsuwan C
J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S35-41. PubMed ID: 23682520
[TBL] [Abstract][Full Text] [Related]
11. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
12. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
[TBL] [Abstract][Full Text] [Related]
13. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
Kim H; Cho WK; Kim YJ; Kim YS; Park W
Gynecol Oncol; 2020 May; 157(2):423-428. PubMed ID: 32139148
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
16. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
Zhao D; Qiu H; Zhang H; Hong L; Zhang G; Xie C
Jpn J Clin Oncol; 2017 Nov; 47(11):1024-1030. PubMed ID: 28973662
[TBL] [Abstract][Full Text] [Related]
19. [Our and foreign experience in the field of radical hysterectomy and lymph node dissection in the treatment of cervical cancer stage IB-IIA].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(1):38-40. PubMed ID: 17469461
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
